Hep C cAg Activators

The term Hep C Activators refers to a class of compounds that can potentiate the host's immune response against the Hepatitis C virus or promote mechanisms leading to viral clearance, not to the direct activation of viral proteins. This class includes immunomodulators that can enhance the effectiveness of the host immune system. Toll-like receptor agonists like Poly I:C, imiquimod, gardiquimod, and resiquimod work by mimicking pathogen-associated molecular patterns, thereby kick-starting the immune system and providing rapid engagement of the antiviral defense mechanisms.

Additionally, checkpoint inhibitors such as nivolumab and pembrolizumab can reverse the exhaustion of T cells, which is often seen in chronic viral infections, thus restoring their ability to combat the virus. Adjuvants, including aluminum hydroxide, are substances added to vaccines to enhance the body's immune response to the provided antigen. These components are especially relevant in the context of vaccines for chronic infections like HCV. Squalamine, despite being primarily known for its antimicrobial properties, may also exert immunomodulatory effects, which can be beneficial in an antiviral context. Collectively, these Hep C Activators engage various arms of the immune system, providing a multifaceted boost to the body's natural defenses and offering support in clearing viral infections.